Plain-English translation of NCT05517811 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is testing whether a special blood test called TEG (thromboelastography) can help doctors better predict which cancer patients will have dangerous blood clots, dangerous bleeding, or cancer recurrence after surgery. TEG measures how well your blood clots in a different way than standard blood tests. The study involves patients with liver, pancreas, bile duct, esophageal, colorectal, or lung cancer who are having surgery, plus healthy people undergoing major surgery for comparison.
Cancer patients who have surgery face higher risks of blood clots and bleeding complications. Standard blood tests don't always predict these problems well. This study aims to find out if this special clotting test can give doctors better warning signs and help them understand why some cancers are more likely to come back after surgery.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will have the special blood clotting test (TEG) done before your cancer surgery and again after surgery to see how your blood clotting changes. The study will also collect some tissue samples from your tumor if you're having surgery. You'll be followed over time to track whether you develop any blood clots, bleeding problems, or cancer recurrence. Your participation helps researchers understand how this blood test can predict surgical complications and cancer outcomes.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
United States
Sponsor
University of Colorado, Denver
Collaborators
Haemonetics Corporation
Enrollment target
~400 participants
Started
June 2022
Primary completion
May 2028
Age range
18 Years – 99 Years
Last updated on clinicaltrials.gov in January 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Tracey MacDermott, BA BS CCRC
University of Colorado, Denver
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.